351 related articles for article (PubMed ID: 29737570)
21. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
22. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
23. Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis.
Dai F; Chen G; Wang Y; Zhang L; Long Y; Yuan M; Yang D; Liu S; Cheng Y; Zhang L
Onco Targets Ther; 2019; 12():4517-4532. PubMed ID: 31354287
[No Abstract] [Full Text] [Related]
24. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
[TBL] [Abstract][Full Text] [Related]
25. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
[TBL] [Abstract][Full Text] [Related]
26. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
27. Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.
Shao MX; Qu AZ; Wang YQ; Zhong YY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6583-6588. PubMed ID: 32633346
[TBL] [Abstract][Full Text] [Related]
28. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of the exocytosis pathway genes in cervical cancer.
Eswaran S; Adiga D; Khan G N; S S; Kabekkodu SP
Am J Med Sci; 2022 Jun; 363(6):526-537. PubMed ID: 34995576
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics prediction of differential miRNAs in non-small cell lung cancer.
Xiao K; Liu S; Xiao Y; Wang Y; Zhu Z; Wang Y; Tong D; Jiang J
PLoS One; 2021; 16(7):e0254854. PubMed ID: 34288959
[TBL] [Abstract][Full Text] [Related]
31. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
Luo HS; Wu DH
Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
[TBL] [Abstract][Full Text] [Related]
32. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
[TBL] [Abstract][Full Text] [Related]
33. The correlation analysis of miRNAs and target genes in metastasis of cervical squamous cell carcinoma.
Zhou J; Liu X; Wang C; Li C
Epigenomics; 2018 Mar; 10(3):259-275. PubMed ID: 29343084
[TBL] [Abstract][Full Text] [Related]
34. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
Andalib KMS; Rahman MH; Habib A
J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
[TBL] [Abstract][Full Text] [Related]
36. A microRNA expression signature for clinical response in locally advanced cervical cancer.
Pedroza-Torres A; Fernández-Retana J; Peralta-Zaragoza O; Jacobo-Herrera N; Cantú de Leon D; Cerna-Cortés JF; Lopez-Camarillo C; Pérez-Plasencia C
Gynecol Oncol; 2016 Sep; 142(3):557-65. PubMed ID: 27423381
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
Liu DF; Wu JT; Wang JM; Liu QZ; Gao ZL; Liu YX
Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
[TBL] [Abstract][Full Text] [Related]
39. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
